aTYR PHARMA Inc
ATYRLatest QuantConomy context for ATYR: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
aTYR PHARMA Inc
QuantConomy has a structured record for ATYR. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- ATYR
- Name
- aTYR PHARMA Inc
- Coverage
- 3 market/data records
- Sources
- alphavantage fmp alpaca sec nasdaq
Recent signals for ATYR
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| passive increase | slightly bullish | 37 | Jul 9, 02:15 AM | Federated Hermes, Inc. increased passive stake in ATYR from 6.10% to 8.68% - (13G - passive investment) - 8,509,678 shares - [weak slightly bullish signal] |
| operating income change | very bullish | 76 | May 15, 12:00 AM | ATYR (Q1 2026, operating income): grew 85.3% (-$77.63M → -$11.44M). [sequential period basis, very bullish signal] |
| eps change | very bullish | 76 | May 15, 12:00 AM | ATYR (Q1 2026, diluted eps): EPS grew 86.3% ($-0.80 → $-0.11). [sequential period basis, very bullish signal] |
FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| ATYR | NASDAQ | alphavantage | Atyr Pharma Inc |
| ATYR | NASDAQ | fmp | aTyr Pharma, Inc. |
| ATYR | NASDAQ | alpaca | aTyr Pharma, Inc. Common Stock |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | SCHIMMEL PAUL | Director | purchase | 100,000 | $0.50 | $49,630 | 4 on EDGAR |
| May 11, 2026 | Gross Jane A | Director | grant | 50,000 | — | — | 4 on EDGAR |
| May 11, 2026 | Coughlin Timothy | Director | grant | 50,000 | — | — | 4 on EDGAR |
| May 11, 2026 | SCHIMMEL PAUL | Director | grant | 50,000 | — | — | 4 on EDGAR |
| May 11, 2026 | BENEVICH ERIC | Director | grant | 50,000 | — | — | 4 on EDGAR |
| May 11, 2026 | Lucas Svetlana | Director | grant | 50,000 | — | — | 4 on EDGAR |
| May 11, 2026 | Zaknoen Sara | Director | grant | 50,000 | — | — | 4 on EDGAR |
| Feb 3, 2026 | DENYES NANCY | General Counsel | exercise | 2,687 | — | — | 4 on EDGAR |
| Feb 3, 2026 | Broadfoot Jill Marie | Chief Financial Officer | exercise | 3,750 | — | — | 4 on EDGAR |
| Feb 3, 2026 | Shukla Sanjay | President and CEO | exercise | 10,375 | — | — | 4 on EDGAR |
| Jan 9, 2026 | DENYES NANCY | General Counsel | grant | 412,500 | — | — | 4 on EDGAR |
| Jan 9, 2026 | Broadfoot Jill Marie | Chief Financial Officer | grant | 412,500 | — | — | 4 on EDGAR |
| Jan 9, 2026 | Shukla Sanjay | President and CEO | grant | 1,500,000 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query ATYR context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access